# Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma

> **NCT03723941** · PHASE3 · COMPLETED · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 40 (actual)

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

- **DRUG:** Cisplatin plus Etoposide
- **OTHER:** Observation or Mitotane

## Key facts

- **NCT ID:** NCT03723941
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-05-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723941, "Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03723941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*